Hi-Tech Responds to "Bullying Tactics" Issued by FDA Warning Letter on DMHA
/PRNewswire/ -- Hi-Tech Pharmaceuticals once again states that FDA's attempt to quasi ban a product by warning letter rather than rulemaking is not the law....
www.prnewswire.com